What is Fluticasone furoate-Vilanterol?

Category: Prescription Drugs

Most popular types: Breo Ellipta Relvar Ellipta

false

Fluticasone-Vilanterol is a combination inhaled corticosteroid and long-acting beta-2-adrenergic agonists. It is used to treat airflow obstruction in patients with chronic obstructive pulmonary disease.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Asthma 58 29
Chronic obstructive pulmonary disease 28 14
Wheezing 5 3
Breathing difficulty 1 0
Bronchitis 1 1
Chronic cough 1 0

Show all 12 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 1
Moderate 2
Mild 5
None 39

Commonly reported side effects and conditions associated with Fluticasone furoate-Vilanterol

Side effect Patients Percentage
Anxious mood 1
Chronic belching 1
Dry mouth 1
Elevated blood sugar (hyperglycemia) 1
Excessive dry mouth 1
Increased anxiety 1

Show all 10 reported side effects

Why patients stopped taking Fluticasone furoate-Vilanterol

Multiple reasons could be selected

Reason Patients Percentage
Doctor's advice 6
Did not seem to work 5
Change in health plan coverage 2
Course of treatment ended 1
Expense 1
Other 1
Side effects too severe 1
See all 15 patients who've stopped taking Fluticasone furoate-Vilanterol

Duration

Stopped taking Fluticasone furoate-Vilanterol

Duration Patients Percentage
Less than 1 month 4
1 - 6 months 4
6 months - 1 year 2
2 - 5 years 4
5 - 10 years 3
Adherence
Adherence Evaluations Percentage
Always 31
Usually 16
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 1
Somewhat hard to take 1
A little hard to take 10
Not at all hard to take 35
Cost per month
Cost per month Evaluations Percentage
$200+ 3
$100-199 0
$50-99 3
$25-49 6
< $25 14
Not specified 21

What people switch to and from

Patients started taking Fluticasone furoate-Vilanterol after stopping:

Treatment Patients Percentage
Fluticasone-Salmeterol (Advair Diskus) 9
Budesonide-Formoterol (Symbicort) 8
Albuterol (Albuterol Inhaler) 5
Tiotropium inhaler (Spiriva HandiHaler) 4
Fluticasone (Flovent) 3

Show all 11 treatments patients report switching from

Patients stopped taking Fluticasone furoate-Vilanterol and switched to:

Treatment Patients Percentage
Fluticasone-Salmeterol (Advair Diskus) 5
Fluticasone-Umeclidinium-Vilanterol (Trelegy Ellipta) 2
Albuterol (Albuterol Inhaler) 1
Budesonide-Formoterol (Symbicort) 1
Olodaterol-Tiotropium (Stiolto Respimat) 1

Show all 7 treatments patients report switching to

Last updated:

2 patient evaluations for Fluticasone furoate-Vilanterol

Mar 15, 2019 (Started Dec 15, 2016)

  • Effectiveness
    Slight (for asthma)
  • Side effects
    None
  • Adherence
    Usually
  • Burden
    A little hard to take
Dosage: 200-25 mcg/puff Daily

Feb 7, 2019 (Started Dec 15, 2016)

  • Effectiveness
    Slight (for asthma)
  • Side effects
    None
  • Adherence
    Usually
  • Burden
    A little hard to take
Dosage: 200-25 mcg/puff Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.

Apr 15, 2017 (Started Dec 15, 2016)

  • Effectiveness
    Slight (for asthma)
  • Side effects
    None
  • Adherence
    Usually
  • Burden
    A little hard to take
Dosage: 200-25 mcg/puff Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.

  • 0 helpful marks

Aug 13, 2018 (Started Jul 01, 2015)

  • Effectiveness
    None (for chronic obstructive pulmonary disease)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take

  • 0 helpful marks
Last updated:
Showing 2 of 2 patient evaluations for Fluticasone furoate-Vilanterol